MML Investors Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

MML Investors Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	19,972 +398	+2%	+$23.3K	﹤0.01%	1833
2026 Q1	$1.06M	Sell	19,574 -13,108	-40%	-$731K	﹤0.01%	1738
2025 Q4	$1.83M	Buy	32,682 +6,608	+25%	+$342K	﹤0.01%	1425
2025 Q3	$1.25M	Buy	+26,074	New	+$1.17M	﹤0.01%	1581
2023 Q1	–	Sell	-5,628	Closed	-$230K	–	2251
2022 Q4	$230K	Sell	5,628 -14,335	-72%	-$597K	﹤0.01%	1951
2022 Q3	$802K	Buy	19,963 +6,632	+50%	+$284K	0.01%	1172
2022 Q2	$560K	Buy	+13,331	New	+$559K	﹤0.01%	1348

Other funds holding XPH

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MWPCG

Measured Wealth Private Client Group Portsmouth, New Hampshire $414M AUM 32.23% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

MML Investors Services's XPH Position: Q2 2026 in Review

MML Investors Services increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 2% in Q2 2026, buying an estimated $23.3K and bringing the position to 19,972 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

MML Investors Services first reported a position in XPH in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.83M in Q4 2025. 47 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

MML Investors Services held 19,972 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.32M as of Q2 2026.
MML Investors Services bought 398 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $23.3K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1833 holding.
MML Investors Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2022 and has held it in 7 quarters since.
MML Investors Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.83M in Q4 2025.
47 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.